Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase
(2012) In Bioorganic & Medicinal Chemistry Letters 22(7). p.9-2474- Abstract
Scaffold hybridization of several natural and synthetic anticancer leads led to the consideration of indenoindolones as potential novel anticancer agents. A series of these compounds were prepared by a diversity-feasible synthetic method. They were found to possess anticancer activities with higher potency compared to etoposide and 5-fluorouracil in kidney cancer cells (HEK 293) and low toxicity to corresponding normal cells (Vero). They exerted apoptotic effect with blocking of cell cycle at G2/M phase.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5dd42054-2ef6-46df-adb0-aba08218995a
- author
- Kashyap, Maneesh ; Das, Dipon ; Preet, Ranjan ; Mohapatra, Purusottam LU ; Satapathy, Shakti Ranjan LU ; Siddharth, Sumit ; Kundu, Chanakya N and Guchhait, Sankar K
- publishing date
- 2012-04-01
- type
- Contribution to journal
- publication status
- published
- keywords
- Animals, Antineoplastic Agents/chemical synthesis, Apoptosis/drug effects, Biomarkers/metabolism, Cell Survival/drug effects, Chlorocebus aethiops, Etoposide/pharmacology, Flow Cytometry, Fluorouracil/pharmacology, G2 Phase Cell Cycle Checkpoints/drug effects, HEK293 Cells, Humans, Indenes/chemical synthesis, Indoles/chemical synthesis, Inhibitory Concentration 50, Vero Cells
- in
- Bioorganic & Medicinal Chemistry Letters
- volume
- 22
- issue
- 7
- pages
- 9 - 2474
- publisher
- Elsevier
- external identifiers
-
- pmid:22381050
- scopus:84858709629
- ISSN
- 0960-894X
- DOI
- 10.1016/j.bmcl.2012.02.007
- language
- English
- LU publication?
- no
- additional info
- Copyright © 2012 Elsevier Ltd. All rights reserved.
- id
- 5dd42054-2ef6-46df-adb0-aba08218995a
- date added to LUP
- 2025-01-30 10:30:38
- date last changed
- 2025-05-09 10:54:50
@article{5dd42054-2ef6-46df-adb0-aba08218995a, abstract = {{<p>Scaffold hybridization of several natural and synthetic anticancer leads led to the consideration of indenoindolones as potential novel anticancer agents. A series of these compounds were prepared by a diversity-feasible synthetic method. They were found to possess anticancer activities with higher potency compared to etoposide and 5-fluorouracil in kidney cancer cells (HEK 293) and low toxicity to corresponding normal cells (Vero). They exerted apoptotic effect with blocking of cell cycle at G2/M phase.</p>}}, author = {{Kashyap, Maneesh and Das, Dipon and Preet, Ranjan and Mohapatra, Purusottam and Satapathy, Shakti Ranjan and Siddharth, Sumit and Kundu, Chanakya N and Guchhait, Sankar K}}, issn = {{0960-894X}}, keywords = {{Animals; Antineoplastic Agents/chemical synthesis; Apoptosis/drug effects; Biomarkers/metabolism; Cell Survival/drug effects; Chlorocebus aethiops; Etoposide/pharmacology; Flow Cytometry; Fluorouracil/pharmacology; G2 Phase Cell Cycle Checkpoints/drug effects; HEK293 Cells; Humans; Indenes/chemical synthesis; Indoles/chemical synthesis; Inhibitory Concentration 50; Vero Cells}}, language = {{eng}}, month = {{04}}, number = {{7}}, pages = {{9--2474}}, publisher = {{Elsevier}}, series = {{Bioorganic & Medicinal Chemistry Letters}}, title = {{Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase}}, url = {{http://dx.doi.org/10.1016/j.bmcl.2012.02.007}}, doi = {{10.1016/j.bmcl.2012.02.007}}, volume = {{22}}, year = {{2012}}, }